Toldot Genetics
Whole Genome Sequencing Tools
Company Overview
Snapshot
Founded in April 2012 by Dvir Dahary and Ami Haviv, Toldot Genetics operates with 1–10 employees. The company was acquired by Geneyx Genomex in October 2020.
Business overview
Toldot Genetics develops and applies algorithm-based tools for whole genome sequencing to assign genetic variations to clinical conditions. The company provides geneticists and physicians with comprehensive analysis packages for exome sequencing data, focusing on identifying causal mutations for rare genetic disorders. Additionally, Toldot Genetics offers tailored services to pharmaceutical and biotechnology companies for their clinical pipelines, from design to deep analysis of sequencing data, incorporating gold-standard tools with proprietary algorithms and software. The company operates within the Health Tech & Life Sciences sector, specifically in Digital Healthcare and Medical Decision Support.
Strategic signal
In October 2020, Toldot Genetics was acquired by Geneyx Genomex, a move that signals consolidation within the NGS sequencing analysis market. This acquisition highlights the strategic value of advanced genomic analysis tools and platforms, indicating a trend towards integrating specialized technologies to enhance clinical and pharmaceutical R&D capabilities.
Log in to access full profile ›Company Intelligence Q&A
- What is Toldot Genetics' primary focus?
- Toldot Genetics focuses on developing and applying algorithm-based tools for whole genome sequencing to link genetic variations with clinical conditions, particularly for identifying causal mutations in rare genetic disorders.
- When was Toldot Genetics acquired?
- Toldot Genetics was acquired by Geneyx Genomex in October 2020.
- What products does Toldot Genetics offer?
- Toldot Genetics offers products such as TGex, Insight, and TGpack, which are tools for genetic analysis and sequencing data interpretation.
- What was a key partnership for Toldot Genetics?
- In February 2015, LifeMap Sciences partnered with Toldot Genetics to support the commercialization of next-generation sequencing variant analysis.
- What was the TGexTM platform?
- In January 2016, LifeMap Sciences, a subsidiary of BioTime, announced the launch of TGexTM, a knowledge-driven NGS analysis platform powered by the GeneCards Suite, which was developed with Toldot Genetics.